Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tao Sheng

Showing results (371-380 of 376) with videos related to

Pageof 38
Sort By:
You have reached the last page of results.This site can display upto 376 results.
American Journal of Human Genetics|April 30, 2013
Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemiaKazuya Kashiyama, Yuka Nakazawa, Daniela T Pilz, et al.
Journal of Medicinal Chemistry|May 28, 2009
1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activityKaren Miller-Moslin, Stefan Peukert, Rishi K Jain, et al.
BMJ (Clinical Research Ed.)|May 28, 2024
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trialMiao-Zhen Qiu, Do-Youn Oh, Ken Kato, et al.
Journal of Medicinal Chemistry|December 1, 2018
Identification of Selective Acyl Sulfonamide-Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (Na<sub>V</sub>) 1.7 with Potent Analgesic ActivityShaoyi Sun, Qi Jia, Alla Y Zenova, et al.
Journal of Medicinal Chemistry|May 9, 2018
Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3- a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNa<sub>V</sub>1.7 Inhibitors for the Treatment of PainThilo Focken, Sultan Chowdhury, Alla Zenova, et al.
Journal of Medicinal Chemistry|March 8, 2021
Discovery of Acyl-sulfonamide Na<sub>v</sub>1.7 Inhibitors GDC-0276 and GDC-0310Brian S Safina, Steven J McKerrall, Shaoyi Sun, et al.
Pageof 38

Showing results (371-380 of 376) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 376 results.
American Journal of Human Genetics|April 30, 2013
Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemiaKazuya Kashiyama, Yuka Nakazawa, Daniela T Pilz, et al.
Journal of Medicinal Chemistry|May 28, 2009
1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activityKaren Miller-Moslin, Stefan Peukert, Rishi K Jain, et al.
BMJ (Clinical Research Ed.)|May 28, 2024
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trialMiao-Zhen Qiu, Do-Youn Oh, Ken Kato, et al.
Journal of Medicinal Chemistry|December 1, 2018
Identification of Selective Acyl Sulfonamide-Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (Na<sub>V</sub>) 1.7 with Potent Analgesic ActivityShaoyi Sun, Qi Jia, Alla Y Zenova, et al.
Journal of Medicinal Chemistry|May 9, 2018
Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3- a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNa<sub>V</sub>1.7 Inhibitors for the Treatment of PainThilo Focken, Sultan Chowdhury, Alla Zenova, et al.
Journal of Medicinal Chemistry|March 8, 2021
Discovery of Acyl-sulfonamide Na<sub>v</sub>1.7 Inhibitors GDC-0276 and GDC-0310Brian S Safina, Steven J McKerrall, Shaoyi Sun, et al.
Pageof 38